C4 Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
C4 Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2019 to Q3 2024.
  • C4 Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 70.6M shares, a 43.2% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 70.6M +21.3M +43.2% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 68.8M +19.8M +40.3% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 68.8M +19.7M +40.2% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 60.5M +11.5M +23.5% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 49.3M +309K +0.63% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 49.1M +187K +0.38% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 49.1M +301K +0.62% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 49M +277K +0.57% Dec 31, 2022 10-K 2024-02-22
Q3 2022 49M +358K +0.74% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 48.9M +498K +1.03% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 48.8M +5.64M +13.1% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 48.7M +5.63M +13.1% Dec 31, 2021 10-K 2023-02-23
Q3 2021 48.6M +47M +2874% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 48.4M Jun 30, 2021 10-Q 2021-08-11
Q1 2021 43.1M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 43.1M +41.6M +2918% Dec 31, 2020 10-K 2022-02-24
Q3 2020 1.63M Sep 30, 2020 10-Q 2020-11-12
Q4 2019 1.43M Dec 31, 2019 10-K 2021-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.